Cargando…
COVID-19 therapy and prevention
Since the outbreak of the new coronavirus pneumonia (COVID-19) in December 2019, more than 23 million people worldwide have been diagnosed with SARS-CoV-2. In response to this pandemic, a global mobilization of scientific, industrial and political support has ensued. However, more than 8 months late...
Autor principal: | Claude-Rosny, Elie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Applied Systems srl
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557156/ https://www.ncbi.nlm.nih.gov/pubmed/33094148 http://dx.doi.org/10.15190/d.2020.10 |
Ejemplares similares
-
Current Approaches to COVID-19: Therapy and Prevention
por: Dixit, Subhal B, et al.
Publicado: (2020) -
COVID-19 and OCD: Potential impact of exposure and response prevention therapy
por: Sheu, Jessica C., et al.
Publicado: (2020) -
Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation
por: Singh, Priya, et al.
Publicado: (2021) -
Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy
por: Martín Giménez, Virna Margarita, et al.
Publicado: (2023) -
Animal models for studying COVID-19, prevention, and therapy: Pathology and disease phenotypes
por: Choudhary, Shambhunath, et al.
Publicado: (2022)